Treatment Patterns and Real-World Outcomes for Locally Advanced or Metastatic Urothelial Cancer in the Era of Immunotherapy

Melanie R. Hassler, Verena Moedlagl, Hanna Hindinger, Johanna Krauter, Sonja Klager,Irene Resch,Nicolai Huebner, Ozan Yurdakul, Heidemarie Ofner,Stephan M. Korn,David D'Andrea,Kilian Gust,Shahrokh F. Shariat

European urology focus（2023）

引用 0|浏览2

暂无评分

摘要

Real-world data show that immune checkpoint inhibitors significantly prolong survival in patients with advanced or metastatic urothelial cancer, particularly in patients staying longer than 6 mo on therapy.

查看译文

关键词

Advanced urothelial cancer,Metastatic urothelial cancer,Chemotherapy,Checkpoint inhibitor,Immunotherapy,Overall survival,Progression-free survival

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要